Bioactive Peptides Against Fungal Biofilms
Infections caused by invasive fungal biofilms have been widely associated with high morbidity and mortality rates, mainly due to the advent of antibiotic resistance. Moreover, fungal biofilms impose an additional challenge, leading to multidrug resistance. This fact, along with the contamination of...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2019.02169/full |
id |
doaj-d9a606cf0e7849c58b156ebefc7dd92b |
---|---|
record_format |
Article |
spelling |
doaj-d9a606cf0e7849c58b156ebefc7dd92b2020-11-24T20:42:49ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-10-011010.3389/fmicb.2019.02169462276Bioactive Peptides Against Fungal BiofilmsKaren G. N. Oshiro0Karen G. N. Oshiro1Gisele Rodrigues2Bruna Estéfani D. Monges3Marlon Henrique Cardoso4Marlon Henrique Cardoso5Octávio Luiz Franco6Octávio Luiz Franco7Octávio Luiz Franco8Programa de Pós-Graduação em Patologia Molecular, Faculdade de Medicina, Universidade de Brasília, Brasília, BrazilS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, BrazilCentro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, BrazilS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, BrazilS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, BrazilCentro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, BrazilPrograma de Pós-Graduação em Patologia Molecular, Faculdade de Medicina, Universidade de Brasília, Brasília, BrazilS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, BrazilCentro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, BrazilInfections caused by invasive fungal biofilms have been widely associated with high morbidity and mortality rates, mainly due to the advent of antibiotic resistance. Moreover, fungal biofilms impose an additional challenge, leading to multidrug resistance. This fact, along with the contamination of medical devices and the limited number of effective antifungal agents available on the market, demonstrates the importance of finding novel drug candidates targeting pathogenic fungal cells and biofilms. In this context, an alternative strategy is the use of antifungal peptides (AFPs) against fungal biofilms. AFPs are considered a group of bioactive molecules with broad-spectrum activities and multiple mechanisms of action that have been widely used as template molecules for drug design strategies aiming at greater specificity and biological efficacy. Among the AFP classes most studied in the context of fungal biofilms, defensins, cathelicidins and histatins have been described. AFPs can also act by preventing the formation of fungal biofilms and eradicating preformed biofilms through mechanisms associated with cell wall perturbation, inhibition of planktonic fungal cells’ adhesion onto surfaces, gene regulation and generation of reactive oxygen species (ROS). Thus, considering the critical scenario imposed by fungal biofilms and associated infections and the application of AFPs as a possible treatment, this review will focus on the most effective AFPs described to date, with a core focus on antibiofilm peptides, as well as their efficacy in vivo, application on surfaces and proposed mechanisms of action.https://www.frontiersin.org/article/10.3389/fmicb.2019.02169/fullantifungal peptidesfungal infectionsfungal biofilmsantimicrobial peptidesmechanisms of action |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Karen G. N. Oshiro Karen G. N. Oshiro Gisele Rodrigues Bruna Estéfani D. Monges Marlon Henrique Cardoso Marlon Henrique Cardoso Octávio Luiz Franco Octávio Luiz Franco Octávio Luiz Franco |
spellingShingle |
Karen G. N. Oshiro Karen G. N. Oshiro Gisele Rodrigues Bruna Estéfani D. Monges Marlon Henrique Cardoso Marlon Henrique Cardoso Octávio Luiz Franco Octávio Luiz Franco Octávio Luiz Franco Bioactive Peptides Against Fungal Biofilms Frontiers in Microbiology antifungal peptides fungal infections fungal biofilms antimicrobial peptides mechanisms of action |
author_facet |
Karen G. N. Oshiro Karen G. N. Oshiro Gisele Rodrigues Bruna Estéfani D. Monges Marlon Henrique Cardoso Marlon Henrique Cardoso Octávio Luiz Franco Octávio Luiz Franco Octávio Luiz Franco |
author_sort |
Karen G. N. Oshiro |
title |
Bioactive Peptides Against Fungal Biofilms |
title_short |
Bioactive Peptides Against Fungal Biofilms |
title_full |
Bioactive Peptides Against Fungal Biofilms |
title_fullStr |
Bioactive Peptides Against Fungal Biofilms |
title_full_unstemmed |
Bioactive Peptides Against Fungal Biofilms |
title_sort |
bioactive peptides against fungal biofilms |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Microbiology |
issn |
1664-302X |
publishDate |
2019-10-01 |
description |
Infections caused by invasive fungal biofilms have been widely associated with high morbidity and mortality rates, mainly due to the advent of antibiotic resistance. Moreover, fungal biofilms impose an additional challenge, leading to multidrug resistance. This fact, along with the contamination of medical devices and the limited number of effective antifungal agents available on the market, demonstrates the importance of finding novel drug candidates targeting pathogenic fungal cells and biofilms. In this context, an alternative strategy is the use of antifungal peptides (AFPs) against fungal biofilms. AFPs are considered a group of bioactive molecules with broad-spectrum activities and multiple mechanisms of action that have been widely used as template molecules for drug design strategies aiming at greater specificity and biological efficacy. Among the AFP classes most studied in the context of fungal biofilms, defensins, cathelicidins and histatins have been described. AFPs can also act by preventing the formation of fungal biofilms and eradicating preformed biofilms through mechanisms associated with cell wall perturbation, inhibition of planktonic fungal cells’ adhesion onto surfaces, gene regulation and generation of reactive oxygen species (ROS). Thus, considering the critical scenario imposed by fungal biofilms and associated infections and the application of AFPs as a possible treatment, this review will focus on the most effective AFPs described to date, with a core focus on antibiofilm peptides, as well as their efficacy in vivo, application on surfaces and proposed mechanisms of action. |
topic |
antifungal peptides fungal infections fungal biofilms antimicrobial peptides mechanisms of action |
url |
https://www.frontiersin.org/article/10.3389/fmicb.2019.02169/full |
work_keys_str_mv |
AT karengnoshiro bioactivepeptidesagainstfungalbiofilms AT karengnoshiro bioactivepeptidesagainstfungalbiofilms AT giselerodrigues bioactivepeptidesagainstfungalbiofilms AT brunaestefanidmonges bioactivepeptidesagainstfungalbiofilms AT marlonhenriquecardoso bioactivepeptidesagainstfungalbiofilms AT marlonhenriquecardoso bioactivepeptidesagainstfungalbiofilms AT octavioluizfranco bioactivepeptidesagainstfungalbiofilms AT octavioluizfranco bioactivepeptidesagainstfungalbiofilms AT octavioluizfranco bioactivepeptidesagainstfungalbiofilms |
_version_ |
1716821681744379904 |